methylprednisolone has been researched along with Ageusia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farinini, D; Inglese, M; Novi, G; Pedemonte, E; Roccatagliata, L; Rolla, C; Rossi, T; Saitta, L | 1 |
| Endo, K; Itoyama, Y; Kawaguchi, N; Misu, T; Miura, E; Nakashima, I; Sugeno, N | 1 |
2 other study(ies) available for methylprednisolone and Ageusia
| Article | Year |
|---|---|
Acute disseminated encephalomyelitis after SARS-CoV-2 infection.
Topics: Ageusia; Brain; Coronavirus Infections; COVID-19; Encephalomyelitis, Acute Disseminated; Evoked Potentials, Visual; Female; Glucocorticoids; Headache; Humans; Hypertension; Hypesthesia; Immunoglobulins, Intravenous; Immunologic Factors; Irritable Mood; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Pupil Disorders; Reflex, Abnormal; Spinal Cord; Vision Disorders; Visual Field Tests | 2020 |
Recurrent hypogeusia in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Topics: Ageusia; Anti-Inflammatory Agents; Humans; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Recurrence | 2012 |